GO
Loading...

Pfizer Inc

More

  • Final Glance: Pharmaceuticals companies Friday, 31 Oct 2014 | 6:04 PM ET

    Baxter International Inc. rose$. 08 or. 1 percent, to $70.14. Bristol-Myers Squibb Co. fell$. 79 or 1.3 percent, to $58.19. Hospira fell$. 54 or 1.0 percent, to $53.70.

  • Most active New York Stock Exchange-traded stocks Friday, 31 Oct 2014 | 2:49 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. Bank of America Corp. rose. 8 percent to $17.16 with 79,411,600 shares traded. Barrick Gold Corp. fell 3.4 percent to $11.87 with 32,994,800 shares traded.

  • Midday Glance: Pharmaceuticals companies Friday, 31 Oct 2014 | 2:49 PM ET

    Baxter International Inc. rose$. 22 or. 3 percent, to $70.28. Hospira fell$. 36 or. 7 percent, to $53.88. Eli Lilly& Co. fell$. 36 or. 5 percent, to $66.44.

  • Early Glance: Pharmaceuticals companies Friday, 31 Oct 2014 | 12:28 PM ET

    Baxter International Inc. rose$. 35 or. 5 percent, to $70.41. Bristol-Myers Squibb Co. fell$. 43 or. 7 percent, to $58.55. Hospira fell$. 05 or. 1 percent, to $54.19.

  • UPDATE 1-FDA panel backs Daiichi's blood thinner Thursday, 30 Oct 2014 | 6:57 PM ET

    Oct 30- A panel of advisers to the U.S. Food and Drug Administration voted 9-1 in favor of approving Japanese drugmaker Daiichi Sankyo Co's blood thinner for use in some patients with atrial fibrillation. According to late-stage trial data submitted by Daiichi, the drug is as effective- and safer than- warfarin, an anticoagulant that has been on the market for more...

  • Final Glance: Pharmaceuticals companies Thursday, 30 Oct 2014 | 6:02 PM ET

    Baxter International Inc. fell$. 35 or. 5 percent, to $70.06. Bristol-Myers Squibb Co. rose $4.82 or 8.9 percent, to $58.98. Hospira rose $2.17 or 4.2 percent, to $54.24.

  • Midday Glance: Pharmaceuticals companies Thursday, 30 Oct 2014 | 1:17 PM ET

    Baxter International Inc. fell$. 79 or 1.1 percent, to $69.62. Bristol-Myers Squibb Co. rose $4.22 or 7.8 percent, to $58.38. Hospira rose $1.34 or 2.6 percent, to $53.41.

  • NEW YORK, Oct 30- The U.S. Securities and Exchange Commission wants to make its $602 million settlement with SAC Capital Advisors hedge fund available to people who say they are victims of illicit trading by a former SAC portfolio manager, according to a lawyer representing them. District Judge Victor Marrero, who is presiding over the SEC's case, must still...

  • Early Glance: Pharmaceuticals companies Thursday, 30 Oct 2014 | 11:28 AM ET

    Baxter International Inc. fell$. 49 or. 7 percent, to $69.92. Bristol-Myers Squibb Co. rose $2.14 or 4.0 percent, to $56.30. Hospira fell$. 25 or. 5 percent, to $51.82.

  • Final Glance: Pharmaceuticals companies Wednesday, 29 Oct 2014 | 6:02 PM ET

    Baxter International Inc. rose$. 09 or. 1 percent, to $70.41. Bristol-Myers Squibb Co. fell$. 04 or. 1 percent, to $54.16. Hospira fell$. 23 or. 4 percent, to $52.07.

  • FDA approves vaccine to block meningitis strain Wednesday, 29 Oct 2014 | 3:32 PM ET

    The Food and Drug Administration said Wednesday it cleared Pfizer's Trumenba to prevent a subtype of Meningococcal disease in people ages 10 to 25. When the bacteria infect the bloodstream they cause sepsis. Last year the University of California, Santa Barbara and Princeton University both experienced separate, unrelated outbreaks of meningococcal...

  • UPDATE 1-Pfizer meningitis vaccine wins U.S. approval Wednesday, 29 Oct 2014 | 3:06 PM ET

    Oct 29- Pfizer Inc has won U.S. approval for its Trumenba vaccine against meningitis, a potentially deadly bacterial disease that has recently caused outbreaks on college campuses, the U.S. Food and Drug Administration said on Wednesday. It is the first approved U.S. vaccine that prevents invasive disease caused by the bacterium Neisseria meningitidis B, a...

  • Midday Glance: Pharmaceuticals companies Wednesday, 29 Oct 2014 | 1:41 PM ET

    Baxter International Inc. rose$. 01 or percent, to $70.33. Bristol-Myers Squibb Co. fell$. 23 or. 4 percent, to $53.97. Hospira fell$. 16 or. 3 percent, to $52.14.

  • Most active New York Stock Exchange-traded stocks Wednesday, 29 Oct 2014 | 1:41 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at 1 p.m.:. AK Steel Holding Corp. rose 1.5 percent to $7.46 with 11,438,400 shares traded. Alcoa Inc. fell 1.3 percent to $16.39 with 14,140,800 shares traded.

  • Early Glance: Pharmaceuticals companies Wednesday, 29 Oct 2014 | 10:53 AM ET

    Baxter International Inc. rose$. 16 or. 2 percent, to $70.48. Bristol-Myers Squibb Co. fell$. 17 or. 3 percent, to $54.03. Hospira rose$. 18 or. 3 percent, to $52.48.

  • Final Glance: Pharmaceuticals companies Tuesday, 28 Oct 2014 | 6:14 PM ET

    Baxter International Inc. rose$. 47 or. 7 percent, to $70.32. Bristol-Myers Squibb Co. rose$. 67 or 1.3 percent, to $54.20. Hospira rose$. 57 or 1.1 percent, to $52.30.

  • Bonds hold losses after weak 2-year note auction Tuesday, 28 Oct 2014 | 2:39 PM ET
    Traders on the floor of the New York Stock Exchange.

    U.S. Treasury yields continued to rise on Tuesday amid data and expectations of Fed action.

  • Midday Glance: Pharmaceuticals companies Tuesday, 28 Oct 2014 | 1:25 PM ET

    Baxter International Inc. rose$. 01 or percent, to $69.86. Bristol-Myers Squibb Co. rose $1.03 or 1.9 percent, to $54.56. Hospira rose$. 15 or. 3 percent, to $51.88.

  • Most active New York Stock Exchange-traded stocks Tuesday, 28 Oct 2014 | 1:25 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. Bank of America Corp. rose 1.3 percent to $16.80 with 67,921,300 shares traded. Cliffs Natural Resources Inc. rose 22.2 percent to $11.29 with 37,589,000 shares traded.

  • Oct 28- U.S. Food and Drug Administration staff reviewers recommended approval of a 60 mg dose of Daiichi Sankyo Co's blood thinner for some atrial fibrillation patients, but suggested limiting its use to those with abnormal kidney function. The drug, edoxaban, is a once-daily anticoagulant that inhibits Factor Xa, a protein that plays a central role in...